RxDoctor Payments Data

Nadia Sutton, MD

Interventional Cardiology · Nashville, TNNPI 1407019938

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Abbott at 35.7% of the total. Reporting peaked in 2022 at $106,885 and has fallen 52.5% since, to $50,735 in 2025. Among interventional cardiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$344,025in general payments, 2019–2025

Across 423 payments — averaging $813.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$123K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$97K
  • ZOLL Circulation Inc$43K
  • Philips North America LLC$33K
  • Boston Scientific$12K
  • Shockwave Medical, Inc$12K
  • plus $24K from 13 others
$74,852in research payments, 2019–2025

Across 13 payments — averaging $5757.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Shockwave Medical, Inc$74K
  • ZOLL Circulation Inc$963

What the payments were for

  • Consulting fees$159,38646%
  • Speaking & faculty fees$135,17839%
  • Travel & lodging$37,30011%
  • Food & beverage$12,1614%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$344,025 in reported general payments places this provider in the 95th percentile of 207 interventional cardiology providers in Tennessee.

See all interventional cardiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$15,815
Medicare patients
46
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium13$435

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →